E N D
About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.
Market Overview- Bio Banking Market The global biobanking market was valued at USD 23.253.6 million in 2018 and is expected to grow at a CAGR of 6.7 per cent over the forecast period. Several offerings, such as consumables and equipment, mainly contribute to the size of the biobanking market. Increasing the prevalence of chronic diseases, increasing demand for value-based care, increasing investment in genomics research, increasing awareness, and a robust cell therapy pipeline are leading to market growth.
Drivers & Restraints - Bio Banking Market Growing awareness of the therapeutic potential of stem cells, increasing the approval of clinical trials in the use of cord blood cells, advances in biobanking, increasing government funding for regenerative medicines, and the development of new technologies for the preservation, storage and processing of stem cells are the primary growth drivers for the stem cell banking industry. Initiatives are being taken by various companies and organizations to increase awareness of biobanking. For example, CordBloodAwareness.org was formed in the United States to increase awareness of umbilical cord blood stem cells. Growing global burdens on chronic diseases, increasing expenditure on health care and public awareness of the therapeutic potential of stem cells are also fuelling the growth of the biobanking market. The strict regulatory framework and high operating and processing costs are major challenges for the growth of the biobanking market. Moreover, socio-ethical issues related to biobanking and high automation costs are hindering the growth of the global market.
For Sample Report :-https://www.vynzresearch.com/healthcare/biobanking-market/request-sample www.vynzresearch.com